September 10, 2020
www.bostonbiotechnologysummit.com The 4th Boston ● Paris Biotechnology Virtual Summit ● Focus on Covid-19 – will be held, via a zoom platform, on Thursday 15 October 2020, 11 AM – 01 PM US EDT [17:00 – 19:00 EU CET] in three sequential panels as below. The Program Committee, listed below*, have convened renowned experts...
July 2, 2020
Dr Shahin Gharakhanian was interviewed on the current Covid-19 pandemic by BIOTECH-FINANCE (issue no.905, Page 7, 29 June 2020), France’s leading Biotechnology business and financial weekly news magazine.Please visit: www.biotech-finances.com
April 3, 2020
Cambridge MA, 02.03.2020. Stroke is listed as the 2nd cause of mortality worldwide according to the World Health Organization. ACTICOR-BIOTECH [CEO: Dr Gilles AVENARD], a leading, fully-funded, PARIS-based, biotechnology company is assessing its novel agent ACT017 as an add on therapy to Standard of Care in AIS: Acute Ischemic Stroke. This year Acticor-Biotech...
November 8, 2019
For the first time in the US, a joint presentation as an invited speaker (ref. below) @ the forthcoming 5th International Conference on Vaccine Research & Development (Boston/Newton, November 2019). This will focus on the clinical development program being initiated by PAR’IMMUNE [Biotech start-up: CEO Dr A. Lachgar, HQ in Lille, France] that...
June 13, 2019
Click here to download the summit report: PDF Click here to download the summit report: Word
May 29, 2019
Cambridge MA, 30 May 2019 – The 3rd Boston Biotechnology Summit will be held on Sunday, 2 June 2019 at the renowned Wistar Institute in Philadelphia (USA), just before the BIO 2019 Convention. The central theme of this third edition will be collaboration, common foundations, research project development, obtaining regulatory approval and the...
March 19, 2019
Since 2016, we have been diligently building bridges between Boston and European Biotechnologies as a way of accelerating the advent of new treatments in response to patient’s needs, globally. Collaboration is becoming an increasingly important component in the next stage of biotechnology’s evolution. There are at least three fundamental reasons: 1) ...
November 19, 2018
In a scientific collaboration with Dr Armelle Cuvillier, Chair & CSO of B-Cell Design, a dynamic biotech company based in Limoges, France, we have presented R&D program results, for the first time, at the 4th International Vaccine R&D Conference, Baltimore MD, 14 November (validated animal model, human cohort study). This program was carried...
June 18, 2018
The 2nd Boston/Paris Biotechnology Summit was held on Sunday 3 June 2018 at the Boston Exchange Conference Center, just prior to the 2018 BIO Convention held in Boston MA. The Boston – Paris Biotechnology Summit is an exclusive, trans-Atlantic bridge designed to foster innovative synergies between biotech and pharma companies, healthcare-focused...
May 31, 2018
Boston-Paris Biotechnology Summit®: Bringing Together Leaders to Bridge Business Partnerships A Day of Learning and Meeting on New Sources of Financing and Strategic Partnerships Boston, Massachusetts – 30 May, 2018 -The BOSTON-PARIS Biotechnology Summit®, an international conference that aims to foster innovation and partnerships...